Delivery Order SPE2DB25D3404-SPE2DB25FUPUA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,344.93 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count package) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency awarded a delivery order valued at $14,416.67 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (quantity: 30 count) with an ultimate completion date of August 20, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, awarded competitively on August 19, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $7,914.33 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) under a firm fixed-price contract. The award, executed on September 2, 2025, with an ultimate completion date of September 3, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for this transaction and is a major pharmaceutical...
- The Defense Logistics Agency awarded a $2,212.01 delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count package) on September 2, 2025, with an ultimate completion date of September 3, 2025. This contract represents a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $16,082.62 on May 27, 2025, for the supply of Kerendia 20 mg tablets (30-count packages). This firm fixed-price delivery order, with an ultimate completion date of May 28, 2025, represents a child contract under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The contract was competitively awarded with no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $5,954.02 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count units) on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award status. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,746.44 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (90-count units) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation on July 15, 2025, with an ultimate completion date of July 16, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a delivery order valued at $19,097.35 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units) on September 17, 2025, with completion expected by September 18, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor...
- The Defense Logistics Agency awarded a delivery order valued at $12,842.64 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, and performance will be completed by August 14, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,737.75 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on September 12, 2025, with completion scheduled for September 15, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPUADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,568.65 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (30-count units), with an ultimate completion date of August 13, 2025. The contract was competitively awarded with no set-aside designation and employs firm fixed-price pricing. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location and will deliver the medication to support federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle enables comprehensive pharmaceutical and medical supply support for military healthcare programs globally and serves as a flexible procurement mechanism for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The arrangement reflects DLA's strategy of establishing pharmaceutical prime vendor contracts to efficiently supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support defense and military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 8/12/25 |